HSV-1 UL42 and UL47 hijack cellular nucleotide synthetic enzyme CAD to promote lytic replication
Journal of Virology · 2026
DOI: 10.1128/jvi.00920-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Chao Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Infection and Immunity, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Virus Replication, Dihydroorotase, Viral Proteins. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Cellular metabolic enzymes are well defined for their roles in metabolism, and their function beyond metabolism is poorly defined. Here, we report that herpes simplex virus 1 (HSV-1) couples evasion of the inflammatory response to metabolic activation to promote lytic replication. Specifically, HSV-1 activates carbamoyl-phosphate synthetase, aspartate transcarbamoylase, and dihydroorotase (CAD), which catalyzes the rate-limiting steps of de novo pyrimidine synthesis. Activated CAD not only fuels de novo nucleotide synthesis but also deamidates RelA. RelA deamidation suppresses NF-κB activation and the inflammatory response while simultaneously upregulating key glycolytic enzymes to promote aerobic glycolysis. Further affinity purification and functional assays identified HSV-1 UL42 and UL47 that interact with and activate CAD, recapitulating the phenotypes of RelA deamidation. Collectively, our work uncovers a role for a metabolic enzyme in coupling immune evasion to metabolic activation through its protein deamidase activity during HSV-1 infection, highlighting a potential therapeutic target. IMPORTANCE Host immune defense and cellular metabolism are two fundamental processes that shape viral pathogenesis. Here, we revealed that herpes simplex virus 1 (HSV-1) activates a nucleotide synthetic enzyme not only to support nucleotide synthesis but also to exploit its unconventional activity for immune evasion and metabolic reprogramming, highlighting a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Infection and Immunity, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, California, USA.
- Department of Microbial Sciences in Health, Global Center for Pathogen Infection, Center for Experimental Therapeutics, Cleveland Clinic Research, Cleveland, Ohio, USA.
ORCID-Profile: Chao Qin, Pinghui Feng
Förderung
- NCI NIH HHS
- NIH HHS
- NIA NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Qin, C., Xie, X., Xie, T., An, Z., Chung, W. C., & Feng, P. (2026). HSV-1 UL42 and UL47 hijack cellular nucleotide synthetic enzyme CAD to promote lytic replication. Journal of Virology. https://doi.org/10.1128/jvi.00920-26
Vancouver
Qin C, Xie X, Xie T, An Z, Chung WC, Feng P. HSV-1 UL42 and UL47 hijack cellular nucleotide synthetic enzyme CAD to promote lytic replication. Journal of Virology. 2026. doi:10.1128/jvi.00920-26
BibTeX
@article{Qin2026,
author = {Qin, Chao and Xie, Xinchi and Xie, Taolin and An, Zhenhao and Chung, Woo-Chang and Feng, Pinghui},
title = {HSV-1 UL42 and UL47 hijack cellular nucleotide synthetic enzyme CAD to promote lytic replication},
journal = {Journal of Virology},
year = {2026},
doi = {10.1128/jvi.00920-26}
}
EUVIMED